Efficacy News and Research

RSS

Breakthrough in hemophilia A treatment: Sobi's ALTUVOCT receives EU marketing authorization

Sobi® today announced the European Commission has granted Marketing Authorization for ALTUVOCT™ (efanesoctocog alfa), for the treatment and prevention of bleeds and perioperative prophylaxis in hemophilia A. ALTUVOCT is a high-sustained factor VIII replacement therapy for all ages and any disease severity.

22 Jun 2024

Transforming care for rheumatoid arthritis patients through symptom monitoring

Researchers at The University of Manchester are to trial a system that allows people living with rheumatoid arthritis to send their daily symptoms securely to their health record, in a first for the NHS.

22 Jun 2024

Tirzepatide emerges as first drug therapy for obstructive sleep apnea

Researchers at University of California San Diego School of Medicine and international collaborators have led a worldwide, advanced study demonstrating the potential of tirzepatide, known to manage type 2 diabetes, as the first effective drug therapy for obstructive sleep apnea (OSA), a sleep-related disorder characterized by repeated episodes of irregular breathing due to complete or partial blockage of the upper airway.

21 Jun 2024

UCF researcher further explores nanotech to improve cancer and disease detection

Early discovery of debilitating diseases such as cancer or dementia is critical in determining treatment and saving lives.

21 Jun 2024

Semaglutide weight loss results linked to diabetes severity

Researchers investigate the weight loss outcomes of semaglutide treatment in obese patients with type 2 diabetes.

21 Jun 2024

Innovative CAR T cell therapy shows promise for relapsed CIDP patients

This study is led by Professor Junnian Zheng and Ming Shi from the Cancer Institute of Xuzhou Medical University, together with the team of Professor Guiyun Cui and Wei Zhang from the Affiliated Hospital of Xuzhou Medical University.

20 Jun 2024

Combining JAK inhibitors with checkpoint inhibitors improves cancer immunotherapy response

Because not all cancer patients respond to a leading type of cancer immunotherapy drug, known as an immune checkpoint inhibitor, scientists explored whether adding janus kinase (JAK) inhibitors – drugs that treat chronic inflammation – could help.

20 Jun 2024

Noninvasive urine test enhances early detection of bladder cancer in patients with hematuria

One of the first signs of bladder cancer can be blood in the urine (hematuria). Investigators developed and analyzed the results of a streamlined and simplified DNA-based urine test to improve the accuracy of early detection of bladder cancer in patients with hematuria.

20 Jun 2024

JAK inhibitor ruxolitinib enhances immunotherapy in Hodgkin lymphoma patients

Checkpoint inhibitor therapies can be thought of as the molecular "brake release" for the immune system.

20 Jun 2024

Several key policies to stop the spread of COVID-19 were generally a good idea in hindsight according to majority of Americans

The Harvard T.H. Chan School of Public Health and the de Beaumont Foundation present findings from a national poll they conducted to obtain public views on COVID-19 pandemic-related policies.

20 Jun 2024

Non-chemotherapy treatment regimen achieves full remission in aggressive B-cell lymphoma

Researchers at the National Institutes of Health (NIH) have developed a non-chemotherapy treatment regimen that is achieving full remissions for some people with aggressive B-cell lymphoma that has come back or is no longer responding to standard treatments.

19 Jun 2024

FDA approves a clinical trial to test the effectiveness of new brain sensor array

The Federal Drug Administration approved a clinical trial to test the effectiveness of an electronic grid that records brain activity during surgery, developed by engineers at the University of California San Diego.

19 Jun 2024

Harnessing post-translational modifications for a tuberculosis booster vaccine

Tuberculosis is still one of the deadliest infectious diseases, causing over one million deaths each year worldwide.

19 Jun 2024

Causal variant-targeted ribonucleic acid treatment for congenital melanocytic nevi

A genetic treatment targeting the causal NRAS c.181C>A mutation in congenital melanocytic naevus.

19 Jun 2024

Oral semaglutide proves effective for type 2 diabetes and weight loss in Dutch study

A recent study from the PIONEER REAL Netherlands trial demonstrated that oral semaglutide effectively manages type 2 diabetes and supports weight loss in adults.

18 Jun 2024

Ethiopian medicinal plants show promise in cervical cancer research

Research focused on collecting and analyzing plants native to Ethiopia is showing promise in the fight against cancer - specifically cervical cancer cells.

18 Jun 2024

New hope for GI cancers: Review analyzes molecular targets and treatment advancements

Gastrointestinal (GI) cancers, encompassing esophageal, gastric, small bowel, and colorectal carcinomas, represent a significant global health burden due to their high incidence and mortality rates.

18 Jun 2024

Gprc5a identified as potential drug target for treating osteoporosis

Osteoporosis is a skeletal condition that leads to the weakening of bones, making them porous, fragile, and prone to breakage.

18 Jun 2024

Existing cancer drug shows promise in blocking alpha-synuclein spread in Parkinson's mice

In studies with genetically engineered mice, Johns Hopkins Medicine researchers say they have identified a potentially new biological target involving Aplp1, a cell surface protein that drives the spread of Parkinson's disease-causing alpha-synuclein.

18 Jun 2024

COVID-19 vaccines reduce infection and complications in pregnant women

The reactogenicity and impact of coronavirus disease 2019 (COVID-19) vaccines on pregnancy outcomes.

18 Jun 2024

Efficacy News and Research

Breakthrough in hemophilia A treatment: Sobi's ALTUVOCT receives EU marketing authorization

Transforming care for rheumatoid arthritis patients through symptom monitoring

Tirzepatide emerges as first drug therapy for obstructive sleep apnea

UCF researcher further explores nanotech to improve cancer and disease detection

Semaglutide weight loss results linked to diabetes severity

Innovative CAR T cell therapy shows promise for relapsed CIDP patients

Combining JAK inhibitors with checkpoint inhibitors improves cancer immunotherapy response

Noninvasive urine test enhances early detection of bladder cancer in patients with hematuria

JAK inhibitor ruxolitinib enhances immunotherapy in Hodgkin lymphoma patients

Several key policies to stop the spread of COVID-19 were generally a good idea in hindsight according to majority of Americans

Non-chemotherapy treatment regimen achieves full remission in aggressive B-cell lymphoma

FDA approves a clinical trial to test the effectiveness of new brain sensor array

Harnessing post-translational modifications for a tuberculosis booster vaccine

Causal variant-targeted ribonucleic acid treatment for congenital melanocytic nevi

Oral semaglutide proves effective for type 2 diabetes and weight loss in Dutch study

Ethiopian medicinal plants show promise in cervical cancer research

New hope for GI cancers: Review analyzes molecular targets and treatment advancements

Gprc5a identified as potential drug target for treating osteoporosis

Existing cancer drug shows promise in blocking alpha-synuclein spread in Parkinson's mice

COVID-19 vaccines reduce infection and complications in pregnant women

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News